Flagship explainer
How Coherus Oncology, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $42.2M | 100% |
| |
| Cost of revenue | $13.8M | 33% |
|
| $28.4M | 67% |
| |
| −$181M | −430% |
| |
| Income before tax | −$183M | −434% |
|
| Income tax | $0 | 0% |
|
| $168M | 398% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001104659-26-025308